Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Nakanishi Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Nakanishi şirketinin toplam hissedar öz sermayesi ¥124.0B ve toplam borcu ¥14.5B olup, bu da borç-öz sermaye oranını 11.7% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ¥156.8B ve ¥32.7B dir. Nakanishi 'in FAVÖK'ü ¥14.3B faiz karşılama oranı -17.8 dur. Şirketin ¥40.6B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

11.7%

Borç/özkaynak oranı

JP¥14.49b

Borç

Faiz karşılama oranı	-17.8x
Nakit	JP¥40.63b
Eşitlik	JP¥124.03b
Toplam yükümlülükler	JP¥32.73b
Toplam varlıklar	JP¥156.76b

Son finansal sağlık güncellemeleri

Here's Why Nakanishi (TSE:7716) Can Manage Its Debt Responsibly

Apr 03

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 7716 'nin kısa vadeli varlıkları ( ¥79.0B ) kısa vadeli yükümlülüklerini ( ¥24.2B ) aşıyor.

Uzun Vadeli Yükümlülükler: 7716 şirketinin kısa vadeli varlıkları ( ¥79.0B ) uzun vadeli yükümlülüklerini ( ¥8.6B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 7716 şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: 7716 şirketinin borç/öz sermaye oranı son 5 yılda 0.1% seviyesinden 11.7% seviyesine yükseldi.

Borç Kapsamı: 7716 'nin borcu işletme nakit akışı ( 81% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: 7716 ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.

Nakanishi Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Here's Why Nakanishi (TSE:7716) Can Manage Its Debt Responsibly

Recent updates

There Is A Reason Nakanishi Inc.'s (TSE:7716) Price Is Undemanding

Nakanishi Inc. to Report Q3, 2024 Results on Nov 14, 2024

Second quarter 2024 earnings released: EPS: JP¥43.22 (vs JP¥56.46 in 2Q 2023)

Nakanishi (TSE:7716) Will Pay A Dividend Of ¥26.00

Dividend of JP¥26.00 announced

Nakanishi (TSE:7716) Has More To Do To Multiply In Value Going Forward

Investor sentiment deteriorates as stock falls 23%

With EPS Growth And More, Nakanishi (TSE:7716) Makes An Interesting Case

Upcoming dividend of JP¥26.00 per share

Nakanishi (TSE:7716) Has Announced A Dividend Of ¥26.00

Nakanishi Inc. to Report Q2, 2024 Results on Aug 09, 2024

Is There An Opportunity With Nakanishi Inc.'s (TSE:7716) 25% Undervaluation?

First quarter 2024 earnings released: EPS: JP¥39.67 (vs JP¥38.83 in 1Q 2023)

Nakanishi's (TSE:7716) Returns Have Hit A Wall

Now 20% undervalued after recent price drop

Final dividend of JP¥26.00 announced

Here's Why Nakanishi (TSE:7716) Can Manage Its Debt Responsibly

Now 21% undervalued after recent price drop

Consensus EPS estimates fall by 21%

Does Nakanishi (TSE:7716) Deserve A Spot On Your Watchlist?

Nakanishi Inc. to Report Q1, 2024 Results on May 10, 2024

Nakanishi Inc. (TSE:7716) announces an Equity Buyback for 1,100,000 shares, representing 1.17% for ¥2,000 million.

New major risk - Earnings quality

Now 21% overvalued

Full year 2023 earnings: EPS exceeds analyst expectations

Nakanishi Inc. Provides Earnings Forecast for the First Half and Fiscal Year Ending December 31, 2024

Price target decreased by 11% to JP¥3,595

Upcoming dividend of JP¥26.00 per share at 2.2% yield

Nakanishi Inc. to Report Fiscal Year 2023 Results on Feb 13, 2024

Consensus EPS estimates increase by 21%, revenue downgraded

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: JP¥167 (vs JP¥40.41 in 3Q 2022)

Nakanishi Inc. Revises Earnings Forecast for the Fiscal Year Ending December 31, 2023

Now 20% undervalued after recent price drop

Price target increased by 9.9% to JP¥4,060

Nakanishi Inc. to Report Q3, 2023 Results on Nov 10, 2023

Nakanishi Inc. Revises Financial Guidance for the Fiscal Year Ending Dec. 31, 2023

Second quarter 2023 earnings released: EPS: JP¥56.46 (vs JP¥42.02 in 2Q 2022)

Nakanishi Inc. (TSE:7716) announces an Equity Buyback for 1,000,000 shares, representing 1.18% for ¥2,500 million.

Upcoming dividend of JP¥24.00 per share at 1.5% yield

Nakanishi Inc. to Report Q2, 2023 Results on Aug 07, 2023

First quarter 2023 earnings released: EPS: JP¥38.83 (vs JP¥36.49 in 1Q 2022)

Nakanishi Inc. Provides Earnings Guidance for First Half and Full Year of Year Ending March 31, 2024

Now 20% undervalued

Full year 2022 earnings: EPS exceeds analyst expectations

Nakanishi Inc. Provides Dividend Guidance for the Year Ending December 31, 2023

Nakanishi Inc., Annual General Meeting, Mar 30, 2023

Now 22% undervalued after recent price drop

Upcoming dividend of JP¥22.00 per share

Now 21% undervalued after recent price drop

Nakanishi Inc. to Report Fiscal Year 2022 Results on Feb 09, 2023

Price target increased to JP¥3,483

Third quarter 2022 earnings released: EPS: JP¥40.41 (vs JP¥31.52 in 3Q 2021)

Third quarter 2022 earnings released: EPS: JP¥40.41 (vs JP¥31.52 in 3Q 2021)

Nakanishi Inc. (TSE:7716) announces an Equity Buyback for 480,000 shares, representing 0.56% for ¥1,000 million.

Now 21% undervalued

Nakanishi Inc. to Report Q3, 2022 Results on Nov 11, 2022

Second quarter 2022 earnings released: EPS: JP¥42.02 (vs JP¥26.45 in 2Q 2021)

Nakanishi Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2022

Consensus revenue estimates increase by 12%

Nakanishi Inc. Announces Establishment of Nomination and Remuneration Committee

Upcoming dividend of JP¥20.00 per share

Nakanishi Inc. to Report Q2, 2022 Results on Aug 09, 2022

Consensus forecasts updated

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Nakanishi Inc. (TSE:7716) announces an Equity Buyback for 500,000 shares, representing 0.58% for ¥1,000 million.

No independent directors

Nakanishi Inc. to Report Q1, 2022 Results on May 12, 2022

Nakanishi Inc. (JASDAQ:7716) announces an Equity Buyback for 250,000 shares, representing 0.29% for ¥500 million.

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin